Large-scale testing (Phase 3)Study completedNCT00290277
What this trial is testing
Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years
Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300